Compound ID |
Compound Name |
Compound Formula |
CP0037352
|
(3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-amino-3-formamidopropanoic acid]-3-[4-(sulfooxy)phenyl]propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid
Show/Hide
|
C49H62N10O16S3
|
3
|
1 |
EC50 = 0.05012 nM
|
|
|
2 |
IC50 = 0.3162 nM
|
|
|
3 |
IC50 = 0.3467 nM
|
|
|
CP0326463
|
(S)-3-[(S)-2-[(S)-2-Acetylamino-3-(1H-indol-3-yl)-propionylamino]-6-(3-o-tolyl-ureido)-hexanoylamino]-N-((S)-1-carbamoyl-2-phenyl-ethyl)-N-methyl-succinamic acid
Show/Hide
|
C41H50N8O8
|
2
|
1 |
EC50 = 501.19 nM
|
|
|
2 |
IC50 = 5011.87 nM
|
|
|
CP0340102
|
4-[[(2R)-1-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexan-2-yl]amino]-4-oxobutanoic acid
Show/Hide
|
C41H54N6O7
|
2
|
1 |
EC50 = 2511.89 nM
|
|
|
2 |
IC50 = 19.95 nM
|
|
|
CP0100788
|
4-[[(1R)-2-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid
Show/Hide
|
C35H42N4O6
|
1
|
1 |
IC50 = 0.138 nM
|
|
|
CP0843275
|
3-(3-{1-[(Isopropyl-phenyl-carbamoyl)-methyl]-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl}-ureido)-benzoic acid
Show/Hide
|
C34H31N5O6
|
1
|
1 |
IC50 = 10 nM
|
|
|
CP0460799
|
2-[2,4-dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-(4-hydroxyphenyl)-N-propan-2-ylacetamide
Show/Hide
|
C33H31N5O5
|
1
|
1 |
IC50 = 15.85 nM
|
|
|
CP0208808
|
1-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)-3-phenylurea
Show/Hide
|
C33H31N5O4
|
2
|
1 |
IC50 = 23.99 nM
|
|
|
2 |
IC50 = 25.12 nM
|
|
|
CP0380382
|
2-[2,4-dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-(4-fluorophenyl)-N-propan-2-ylacetamide
Show/Hide
|
C33H30FN5O4
|
1
|
1 |
IC50 = 31.62 nM
|
|
|
CP0380803
|
4-[[2-[2,4-dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]acetyl]-propan-2-ylamino]benzoic acid
Show/Hide
|
C34H31N5O6
|
1
|
1 |
IC50 = 39.81 nM
|
|
|
CP0424130
|
2-[2,4-Dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl]-N-isopropyl-N-(4-methoxy-phenyl)-acetamide
Show/Hide
|
C34H33N5O5
|
1
|
1 |
IC50 = 50.12 nM
|
|
|
CP0421473
|
2-[2,4-dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-(4-morpholin-4-ylphenyl)-N-propan-2-ylacetamide
Show/Hide
|
C37H38N6O5
|
1
|
1 |
IC50 = 158.49 nM
|
|
|
CP0418992
|
4-[[(2R)-1-[[(2S)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexan-2-yl]amino]-4-oxobutanoic acid
Show/Hide
|
C41H54N6O7
|
1
|
1 |
IC50 = 177.83 nM
|
|
|
CP0403059
|
methyl 2-[[2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]carbamoyl]indole-1-carboxylate
Show/Hide
|
C37H33N5O6
|
1
|
1 |
IC50 = 199.53 nM
|
|
|
CP0398472
|
4-[[(2S)-2-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexyl]amino]-4-oxobutanoic acid
Show/Hide
|
C41H54N6O7
|
1
|
1 |
IC50 = 223.87 nM
|
|
|
CP0923053
|
N-(4-Dimethylamino-phenyl)-2-[2,4-dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl]-N-isopropyl-acetamide TFA
Show/Hide
|
C37H37F3N6O6
|
1
|
1 |
IC50 = 251.19 nM
|
|
|
CP0424987
|
2-[3-methyl-2,4-dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide
Show/Hide
|
C34H33N5O4
|
1
|
1 |
IC50 = 281.84 nM
|
|
|
CP0527495
|
N-[2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-1H-indole-2-carboxamide
Show/Hide
|
C35H31N5O4
|
1
|
1 |
IC50 = 316.23 nM
|
|
|
CP0467375
|
2-[3-ethyl-2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide
Show/Hide
|
C36H36N4O4
|
1
|
1 |
IC50 = 794.33 nM
|
|
|
CP0302171
|
2-[2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide
Show/Hide
|
C34H32N4O4
|
1
|
1 |
IC50 = 831.76 nM
|
|
|
CP0409031
|
N-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-N-phenyl-2-(phenylcarbamoylamino)acetamide
Show/Hide
|
C26H28N4O3
|
1
|
1 |
IC50 = 1584.89 nM
|
|
|
CP0464819
|
4-[[(2S)-2-[[(2S)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexyl]amino]-4-oxobutanoic acid
Show/Hide
|
C41H54N6O7
|
1
|
1 |
IC50 = 7079.46 nM
|
|
|
CP0101581
|
2-[3-methyl-2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide
Show/Hide
|
C35H34N4O4
|
1
|
1 |
IC50 = 8317.64 nM
|
|
|
CP0378374
|
2-[3-benzyl-2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide
Show/Hide
|
C41H38N4O4
|
1
|
1 |
IC50 = 8912.51 nM
|
|
|
CP0431640
|
(4R)-5-oxo-5-(N-[2-oxo-2-(N-propan-2-ylanilino)ethyl]anilino)-4-(phenylcarbamoylamino)pentanoic acid
Show/Hide
|
C29H32N4O5
|
1
|
1 |
IC50 = 10000 nM
|
|
|
CP0373683
|
(4R)-5-(N-[2-(4-methoxy-N-propan-2-ylanilino)-2-oxoethyl]anilino)-5-oxo-4-(phenylcarbamoylamino)pentanoic acid
Show/Hide
|
C30H34N4O6
|
1
|
1 |
IC50 = 31622.78 nM
|
|
|